Back to News
Market Impact: 0.1
Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development
Source: globenewswire.com
Healthcare & Biotech
A collaboration aims to improve clinical-trial planning and expand patient access to biomarker-matched studies in Australia. The article provides no details on the parties, financial terms, or expected scale.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
- Moderna shares plunge after leak of partial cancer vaccine data
- Moderna's stock tumbles after reported leak of data for cancer vaccine
- Palmer Luckey teams with dire wolf billionaire Ben Lamm to launch $200 million Warhound, unleashing genetically engineered clone dogs of war
- Zai Lab raises $250 million in private placement financing
- Why Moderna stock plunged despite positive cancer vaccine trail results?